Healthy Clinical Trial
Official title:
The Effect of Kinesiotaping on Bioelectrical Muscle Activity
| Verified date | September 2021 |
| Source | Bezmialem Vakif University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The aim of the investigator's study is to analyze the effect of kinesiotaping (KT) on the electrical activity of the muscle by using time and frequency domain analysis of the electromyography (EMG) signals.
| Status | Completed |
| Enrollment | 38 |
| Est. completion date | August 13, 2021 |
| Est. primary completion date | August 12, 2020 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 30 Years |
| Eligibility | Inclusion Criteria: - To be right-handed-dominant - To have normal or corrected vision - To have no formal history of any resistance training. Exclusion Criteria: - To have history of neurological or recent musculoskeletal injury |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Bezmialem Vakif University | Istanbul |
| Lead Sponsor | Collaborator |
|---|---|
| Bezmialem Vakif University | Istanbul University-Cerrahpasa |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The first assessment of electromyographic activity | The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device before KT for KT group or as a first assessment of the control group. The test will be repeated three times. | at inclusion | |
| Primary | The second assessment of electromyographic activity | The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device immediately after KT application for KT group or at 10th minutes after the first assessment as a second assessment of the control group. The test will be repeated three times. | after KT application for KT group or at 10th minutes after the first assessment | |
| Primary | The third assessment of electromyographic activity | The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device at 30 minutes after the second assessment. The test will be repeated three times. | 30 minutes after the second assessment | |
| Primary | The last assessment of electromyographic activity | The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device at 24 hours after KT application or the second assessment. The test will be repeated three times. | at 24 hours after KT application or the second assessment | |
| Secondary | The first assessment of maximum isometric voluntary contraction torque | The produced elbow flexion torque during first EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer. | at inclusion | |
| Secondary | The second assessment of maximum isometric voluntary contraction torque | The produced elbow flexion torque during second EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer. | after KT application for KT group or at 10th minutes after the first assessment | |
| Secondary | The third assessment of maximum isometric voluntary contraction torque | The produced elbow flexion torque during third EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer. | 30 minutes after the second assessment | |
| Secondary | The last assessment of maximum isometric voluntary contraction torque | The produced elbow flexion torque during the last EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer. | at 24 hours after KT application or the second assessment |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |